SIEBERT JOHN M 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Aug 12, 2021
Insider Transaction Report
Form 4
SIEBERT JOHN M
Director
Transactions
- Exercise/Conversion
Director Stock Option (Right to Buy)
2021-08-11−15,000→ 0 totalExercise: $12.98From: 2017-03-01Exp: 2026-03-01→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2021-08-11$12.98/sh+15,000$194,700→ 75,953 total